These FTSE 250 shares are on my Stocks and Shares ISA shortlist right now

Which are best for a Stocks and Shares ISA, FTSE 100 or FTSE 250 shares? Here are two from the 250 that I like the look of.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

What’s the best mix of shares to put into a Stocks and Shares ISA? That depends on individual circumstances and investing strategies. My investing strategy these days is focused mainly on stocks paying progressive dividends. But I’m flexible, and I’m happy to add the occasional growth stock. I’m also open to both FTSE 100 shares and FTSE 250 shares.

Today I’m looking at a couple of FTSE 250 shares that I have on my shortlist. First up is Mediclinic International (LSE: MDC), which released a Q3 trading update Friday. The private healthcare company, with operations in the Middle East and Southern Africa, reported a 2.5% rise in Q3 revenue.

Coping with Covid-19

CEO Dr Ronnie van der Merwe said: “Through the third quarter of our financial year, a more severe second wave of Covid-19 cases has placed greater demand on our acute care capacity.” So far, Mediclinic says it has cared for more than 30,000 Covid-19 patients. And it’s heavily into supporting vaccine rollout plans.

What’s the investment proposition? After a tough few years, I see Mediclinic as a recovery candidate. I won’t buy into a recovery stock until I see signs of the actual recovery. And I think that’s even more important with potentially more volatile FTSE 250 shares. But I think I’m seeing it in 2021.

The company looks to be in a strong liquidity position, with cash and available facilities of £660m at December 2020. It’s reducing debt too. Cash conversion currently stands at 59%, which is well below the target of 90%-100%, but is better than the 42% rate in the first half. Will Mediclinic be one of the FTSE 250 shares I buy in 2021? I’m going to wait for the full-year picture at least, and possibly until I see further cash conversion improvement.

Exciting FTSE 250 shares?

When we think of FTSE 250 shares, we often think of more exciting companies with rapid growth prospects. Well, that doesn’t exactly describe my second pick, Ibstock (LSE: IBST). It makes bricks. And concrete construction items. Dull and boring? Maybe. But they’re essential products with strong long-term demand.

I say long term, as Ibstock has suffered in the Covid-19 pandemic. As the construction industry was severely hampered, the Ibstock share price was hammered in early 2020. It’s not alone in that respect among FTSE 250 shares, many of which have experienced scary volatility. Ibstock has made one of the bigger recoveries since the November market uptick though. But it’s still down 28% over the past 12 months.

I’m seeing resilience

The firm’s 2020 trading update is showing signs of improvement. The release, on Thursday, said: “The strong recovery in market conditions through the second half enabled the group to achieve revenues of around £315m for the full year, down by 23% compared with 2019, with second-half performance down by approximately 10% year-on-year.”

That’s still a tough year, and the new quarter could be hit by the latest lockdown. But I think it underscores the long-term demand for building products. Ibstock expects 2020 EBITDA a little above its previous guidance of £50m, which I find reassuring. I’ll wait and see what the results say. But these two FTSE 250 shares are definitely on my Stocks and Shares ISA shortlist.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Ibstock. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »